跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BUPRENORPHINE AUP buprenorphine 30 microgram/hour transdermal drug delivery system sachet - TGA Drug Approval Details
Approvals
/
TGA
/
BUPRENORPHINE AUP buprenorphine 30 microgram/hour transdermal drug delivery system sachet
Approved
STANDARD
BUPRENORPHINE AUP buprenorphine 30 microgram/hour transdermal drug delivery system sachet
AU Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
9afb3671aaa98f8d
Company
AU Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
9afb3671aaa98f8d
Product Name
BUPRENORPHINE AUP buprenorphine 30 microgram/hour transdermal drug delivery system sachet
Artg Id
398555
Artg Name
BUPRENORPHINE AUP buprenorphine 30 microgram/hour transdermal drug delivery system sachet
Sponsor
AU Pharma Pty Ltd
Artg Date
2023-11-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
9afb3671aaa98f8d
Type
Standard
Back to TGA Approvals
